I grew up in northern Kazakhstan and pursued my undergraduate studies at Nazarbayev University where I initially developed a strong interest in synthetic medicinal chemistry that later grew into a curiosity of how biomimetic organic molecules arrange in a bulk. This brought me into expanding my field expertise by diving into bio- and pharmaceutical materials science through the Erasmus Mundus Joint Master’s Degree programme where I, ultimately, addressed "big pill burden" issue by working on co-amorphous and co-crystalline systems of poorly soluble drugs at Johnson & Johnson Innovative Medicine . During my PhD at Cambridge, I am eager to explore computational approaches to address the limitations I encountered during my experimental research in both academia and industry related to novel drug formulations. I truly believe that predictive modeling that I want to develop can significantly accelerate drug formulation and enable the development of therapies that are often overlooked by large pharmaceutical companies. My personal aim is to contribute into making medicines more accessible worldwide by providing solution to time-consuming and ineffective approaches currently present in big pharmaceutical industry.